PMID: 2095302Dec 1, 1990Paper

Mental outcome following encephaloduroarteriosynangiosis in children with moyamoya disease with the onset earlier than 5 years of age

Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery
Y MatsushimaK Ohno

Abstract

The mental prognosis of children with moyamoya disease, in whom the onset was when they were younger than 5 years of age, has been reported to be very poor. We studied the mental outcome of these patients after encephaloduroarteriosynangiosis (EDAS) in relation to the age at the onset of the disease and the age at operation. For patients in whom the onset of moyamoya disease occurs when they are younger than 2 years of age, the prognosis is very poor with regard to mental abilities even if they have an operation within a year after the onset. Slight hope remains if the operation is within 3 months of the onset. For patients in whom the disease begins when they are 2-5 years of age, EDAS performed before the age of 9 years may result in a good outcome with regard to mental ability, as well as resolution of the paroxysmal symptoms and cerebral revascularization.

References

May 1, 1987·Journal of Neurosurgery·M V OldsH Schutz

❮ Previous
Next ❯

Citations

Feb 1, 1996·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·J FujiwaraH Takita
Feb 4, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Kee Ook Lee, Kyung-Yul Lee
Aug 2, 2012·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Chang Hyun OhJoonho Chung
Jun 3, 2011·Neurosurgical Focus·David G WeinbergBernard R Bendok
Dec 23, 2006·Journal of Neurosurgery·Christian Sainte-RoseMarie Bourgeois
Sep 6, 2013·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Yen-Hsuan HsuChi-Cheng Yang
Feb 18, 2014·Journal of Neurosurgery. Pediatrics·Eric M JacksonEdward R Smith
Apr 17, 1998·Brain & Development·M BowenG K Steinberg
Dec 17, 2011·AJNR. American Journal of Neuroradiology·M A MogensenL J Dorfman
Apr 24, 2013·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Akira NakamizoTomio Sasaki
Apr 13, 2013·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S-H SuY-F Wu
Mar 6, 2015·Neurologia Medico-chirurgica·Yasushi TakagiUNKNOWN COSMO-Japan Study Group
Aug 17, 2006·Pediatrics International : Official Journal of the Japan Pediatric Society·Atsushi ImamuraTatsuaki Hattori
Jun 25, 2014·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Yoshio ArakiSusumu Miyamoto
Nov 2, 2014·Journal of Neurosurgery·Won-Sang ChoChang Wan Oh
Oct 23, 2008·Lancet Neurology·Satoshi Kuroda, Kiyohiro Houkin
Jun 1, 1997·Archives of Physical Medicine and Rehabilitation·D P MooreS N Macciocchi
Mar 6, 2003·Neurologic Clinics·Karen S Carvalho, Bhuwan P Garg
Jun 1, 1997·Stroke; a Journal of Cerebral Circulation·T IshikawaH Abe
Jun 27, 2008·Neurosurgery·Peter KarzmarkGary K Steinberg
Jul 17, 2015·Journal of Korean Neurosurgical Society·Kyu-Won ShimDong-Seok Kim
Apr 22, 2018·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·WooHyun KimKyu-Won Shim
Aug 19, 2011·Neurosurgery·Peter KarzmarkLeslie J Dorfman
Oct 25, 2020·Developmental Medicine and Child Neurology·Sabina SerraNadia Khan
May 8, 2021·Pediatric Neurology·Matsanga Leyila KasekaNomazulu Dlamini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.